TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10432413

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 14
Study: 7607717

Group type: EXPERIMENTAL
Intervention: felodipine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study: 2215105

Group type: EXPERIMENTAL
Intervention: Propofol (2.5 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopentone (5 mg/kg)
Number of subjects: 40
Study: 576328

Group type: EXPERIMENTAL
Intervention: Multiphasic screening group (SG)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Chart abstract group (AG)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Chart review group (RG)
Number of subjects: 112
Study: 31277154

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tongue scraper
Number of subjects: 40
Study: 28721881

Group type: EXPERIMENTAL
Intervention: Postoperative radiation therapy (PORT) at 57.6 Gy or 63 Gy for lower-risk group; 63 Gy or 68.4 Gy for higher-risk group, all at 1.8 Gy per fraction.
Number of subjects: 264
Study: 26297187

Group type: EXPERIMENTAL
Intervention: Transfusion of plasma products
Number of subjects: 14

Group type: COMPARATOR
Intervention: Infusion of albumin solution
Number of subjects: 14
Study: 23176678

Group type: EXPERIMENTAL
Intervention: Fluoridated milk (5 ppm fluoride, 200 ml daily)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-fluoridated milk (200 ml daily)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study: 21777153

Group type: EXPERIMENTAL
Intervention: 10-second rest interval group (n = 8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 1-minute rest interval group (n = 8)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups (10s and 1min)
Number of subjects: 16
Study: 19324954

Group type: EXPERIMENTAL
Intervention: Mandibular advancement device (MAd)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 59
Study: 16676826

Group type: EXPERIMENTAL
Intervention: Balloon catheter dilation of sinus ostia
Number of subjects: 10
Study: 15451898

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection of the pylorus (200 units)
Number of subjects: 8
Study: 11165992

Group type: EXPERIMENTAL
Intervention: Various treatment and prevention options for NSAID-associated ulcers
Number of subjects: 0
Study: 10890384

Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL2) 5 million units/m2 once daily by constant intravenous infusion (CI) 5 days/week for 2 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Interleukin-2 (IL2) 5 million units/m2 once daily by subcutaneous bolus (SB) injection 5 days/week for 2 weeks
Number of subjects: 22
Study: 8792180

Group type: EXPERIMENTAL
Intervention: 100 micrograms/24 h estradiol‐17‐beta
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1636702

Group type: EXPERIMENTAL
Intervention: +T3 group
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cold exposure
Number of subjects: 16

Group type: COMPARATOR
Intervention: ‐T3 group
Number of subjects: 16
Study: 6733832

Group type: EXPERIMENTAL
Intervention: Seated condition
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standing condition
Number of subjects: 10

Group type: COMPARATOR
Intervention: One-leg condition
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Two-legs condition
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cued stepping
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Self-paced stepping
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Training sessions (10 sessions)
Number of subjects: 10
Study: 30001745

Group type: EXPERIMENTAL
Intervention: Lotilaner (Credelio™) at 26 mg/kg (1×)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lotilaner (Credelio™) at 78 mg/kg (3×)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lotilaner (Credelio™) at 130 mg/kg (5×)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (sham-dosed)
Number of subjects: 32
Study: 27596059

Group type: EXPERIMENTAL
Intervention: 1-h plasma glucose >8.6mmol/l (155mg/dl)
Number of subjects: 1970

Group type: COMPARATOR
Intervention: 1-h plasma glucose ≤8.6mmol/l (155mg/dl) and 2-h-PG <7.8mmol/l (140mg/dl)
Number of subjects: 1970
Study: 24275482

Group type: EXPERIMENTAL
Intervention: Silver nitrate cautery
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 22379112

Group type: EXPERIMENTAL
Intervention: Echocardiographic assessment of end-diastolic interventricular septal wall thickness (IVSTd)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Assessment of myocardial mass and left ventricular function
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Correlation analysis of regional myocardial function
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Assessment of neurological function
Number of subjects: 205
Study: 19380175

Group type: EXPERIMENTAL
Intervention: Concomitant treatment (gemcitabine for a maximum of 6 cycles plus cetuximab until progression)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sequential treatment (gemcitabine for a maximum of 6 cycles followed by cetuximab)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Concomitant treatment (CALC1-E)
Number of subjects: 100
Study: 17601037

Group type: EXPERIMENTAL
Intervention: Pharmacological cardioversion (PC) with nibentan
Number of subjects: 97

Group type: COMPARATOR
Intervention: Electrical cardioversion (EC)
Number of subjects: 97
Study: 16261973

Group type: EXPERIMENTAL
Intervention: Three-dimensional, computer-based, virtual training simulator
Number of subjects: 167

Group type: COMPARATOR
Intervention: Standard emergency medical technician training
Number of subjects: 167
Study: 12355477

Group type: EXPERIMENTAL
Intervention: CD34-selected cells
Number of subjects: 33

Group type: COMPARATOR
Intervention: Unmanipulated cells
Number of subjects: 33
Study: 9870121

Group type: EXPERIMENTAL
Intervention: Screening questionnaires placed in charts with concerns highlighted for referrals (experimental group of 209 subjects)
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Screening and treatment (experimental group)
Number of subjects: 619

Group type: COMPARATOR
Intervention: Usual care (control groups)
Number of subjects: 619
Study: 7731498

Group type: EXPERIMENTAL
Intervention: Hexarelin (2 micrograms/kg i.v.)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hexarelin (2 micrograms/kg i.v.) + GHRH (2 micrograms/kg i.v.)
Number of subjects: 6

Group type: COMPARATOR
Intervention: GHRH (2 micrograms/kg i.v.)
Number of subjects: 6
Study: 2233598

Group type: EXPERIMENTAL
Intervention: Nitrendipine (20 mg/day)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Nitrendipine (20 mg/day) + Acebutolol (200 mg/day)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Nitrendipine (20 mg/day) + Hydrochlorothiazide (25 mg/day)
Number of subjects: 34
Study: 30826468

Group type: EXPERIMENTAL
Intervention: Negative content (criticism)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Hostile tone of feedback
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Negative tone with negative content
Number of subjects: 152

Group type: COMPARATOR
Intervention: Neutral content
Number of subjects: 152

Group type: COMPARATOR
Intervention: Neutral tone
Number of subjects: 152
Study: 29215160

Group type: EXPERIMENTAL
Intervention: STAN2007
Number of subjects: 151

Group type: COMPARATOR
Intervention: FIGO2015
Number of subjects: 151

Group type: COMPARATOR
Intervention: SSOG2017
Number of subjects: 151

Group type: COMPARATOR
Intervention: Old and new CTG classification systems
Number of subjects: 151
Study: 26945347

Group type: EXPERIMENTAL
Intervention: Psychosocial status indicators (depression, anxiety, social support) assessed at enrollment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline depressive symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline anxiety levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline social support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Number of stigmatizing experiences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychosocial determinants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation of psychosocial interventions to reduce depression and anxiety
Number of subjects: 0
Study: 24956095

Group type: EXPERIMENTAL
Intervention: Test implants with platform switching
Number of subjects: 53

Group type: COMPARATOR
Intervention: Similar nonplatform-switched controls
Number of subjects: 53
Study: 22067112

Group type: EXPERIMENTAL
Intervention: Reduced carbohydrate diet (SPEC: 42% energy from CHO)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard carbohydrate diet (STAN: 55% energy from CHO)
Number of subjects: 26
Study: 20634594

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 904

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 904
Study: 18567650

Group type: EXPERIMENTAL
Intervention: Linear Torsional combined with Ultrasound power (Linear Tor+US group, n = 66)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 100% Fixed Torsional group (Fixed Tor group, n = 65)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Conventional Ultrasound burst group (US group, n = 67)
Number of subjects: 198
Study: 16037143

Group type: EXPERIMENTAL
Intervention: ondansetron (0.1 mg/kg IV)
Number of subjects: 670

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 670
Study: 12421239

Group type: EXPERIMENTAL
Intervention: Levofloxacin (100 mg once a day) with Erythromycin (200 mg three times a day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Erythromycin (200 mg three times a day)
Number of subjects: 23
Study: 10696321

Group type: EXPERIMENTAL
Intervention: Topical 0.3% ciprofloxacin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Topical 0.3% ofloxacin
Number of subjects: 32
Study: 8698859

Group type: EXPERIMENTAL
Intervention: Cortisol infusion during euglycemia (day 1)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Antecedent hypoglycemia (day 1)
Number of subjects: 16
Study: 1679299

Group type: EXPERIMENTAL
Intervention: 0.6% metipranolol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.3% metipranolol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.6% or 0.3% metipranolol
Number of subjects: 24
Study: 6213126

Group type: EXPERIMENTAL
Intervention: Oral administration of verapamil (single dose of 80 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intravenous administration of verapamil (single dose of 10 mg in 45 minutes)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 15
Study: 30883748

Group type: EXPERIMENTAL
Intervention: Coronally Advanced Flap (CAF)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Laterally Positioned Flap (LPF)
Number of subjects: 36
Study: 27017157

Group type: EXPERIMENTAL
Intervention: External task‐focused facilitation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 10
Study: 26018599

Group type: EXPERIMENTAL
Intervention: ReCharge ice cream (100g for 2 weeks before and 6 weeks after chemotherapy)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: ReCharge ice cream
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 24480604

Group type: EXPERIMENTAL
Intervention: Kangaroo holding (1h of daily skin-to-skin contact on the chest of mother)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Blanket holding (dressed and held in mother's arms)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (no holding restrictions, received weekly brief social visits)
Number of subjects: 79
Study: 21540805

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 40 mg bolus injection
Number of subjects: 71

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 71
Study: 19417232

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Traditional rowing training (CT)
Number of subjects: 10
Study: 17285368

Group type: EXPERIMENTAL
Intervention: Gallbladder aspiration before dissection (Group A, n = 100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No gallbladder aspiration (Group B, n = 100)
Number of subjects: 200
Study: 15528034

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (1 g/d for a week)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Diving apnea (both groups)
Number of subjects: 7
Study: 11182045

Group type: EXPERIMENTAL
Intervention: Biafine
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Lipiderm
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 74
Study: 9512083

Group type: EXPERIMENTAL
Intervention: HP 228 (30 microg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Morphine (0.15 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: HP 228 (30 microg/kg) plus Morphine (0.15 mg/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 8062152

Group type: EXPERIMENTAL
Intervention: 1 microgram of 1 alpha(OH)D3 daily
Number of subjects: 80

Group type: COMPARATOR
Intervention: Inactive placebo
Number of subjects: 80
Study: 2543199

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 60
Study: 29330101

Group type: EXPERIMENTAL
Intervention: Telephone-based weight loss support (6-month program)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study: 26866508

Group type: EXPERIMENTAL
Intervention: sorghum biscuits
Number of subjects: 40

Group type: COMPARATOR
Intervention: wheat control
Number of subjects: 40
Study: 25633911

Group type: EXPERIMENTAL
Intervention: Intervention group (IG) - outpatient (unsupervised) cardiac rehabilitation (CR) primarily centered on a progressive walking program
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (CG) - usual care
Number of subjects: 88
Study: 24344445

Group type: EXPERIMENTAL
Intervention: ADVATE (recombinant anti‐hemophilic factor VIII, plasma‐free method [octocog alfa])
Number of subjects: 850
Study: 20937116

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise test (CPET)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Plasma creatine kinase (CK) levels
Number of subjects: 15
Study: 18216512

Group type: EXPERIMENTAL
Intervention: Suprathel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Omiderm
Number of subjects: 30
Study: 16214634

Group type: EXPERIMENTAL
Intervention: Titrated oral appliance
Number of subjects: 14
Study: 12360125

Group type: EXPERIMENTAL
Intervention: Revascularization (n = 23)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Medical therapy (n = 33)
Number of subjects: 56
Study: 9989538

Group type: EXPERIMENTAL
Intervention: Intravenous doxycycline (100 mg every 12 hours)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (other antibiotic regimens)
Number of subjects: 87
Study: 7760260

Group type: EXPERIMENTAL
Intervention: Honest responding (N = 62)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Defensive responding (N = 62)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Forensic subjects suspected of abusing psychoactive substances (N = 54)
Number of subjects: 178
Study: 2271433

Group type: EXPERIMENTAL
Intervention: Yellow fever vaccine
Number of subjects: 77
Study: 7246701

Group type: EXPERIMENTAL
Intervention: Neutral hypotonic tear preparations
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Isotonic or near‐isotonic alkaline tear substitutes
Number of subjects: 15
Study: 31546576

Group type: EXPERIMENTAL
Intervention: Salt reduced bread
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Salt reduced bread and dietary counseling
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard bread
Number of subjects: 120
Study: 28158963

Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 100
Study: 25854932

Group type: EXPERIMENTAL
Intervention: Bushen Capsule (BSC), orally treated for 3 months
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo, treated for 3 months
Number of subjects: 44
Study: 24074830

Group type: EXPERIMENTAL
Intervention: Fibular fixation using a 3.5‐mm Limited Contact Dynamic Compression Plate (LC‐DCP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Interlocking nailing of the tibia without fibular fixation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 60
Study: 21843690

Group type: EXPERIMENTAL
Intervention: Individualized computer-based intervention
Number of subjects: 463

Group type: COMPARATOR
Intervention: Enhanced standard care counseling intervention
Number of subjects: 463
Study: 19484669

Group type: EXPERIMENTAL
Intervention: Nebulization and non-invasive positive pressure with IPAP = 15 cm H(2)O and EPAP = 10 cm H(2)O (Experimental Group 2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nebulization and non-invasive positive pressure with IPAP = 15 cm H(2)O and EPAP = 5 cm H(2)O (Experimental Group 1)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Nebulization with the use of an unpressured mask (Control Group)
Number of subjects: 36
Study: 17259189

Group type: EXPERIMENTAL
Intervention: Decaffeinated instant coffee (629 women)
Number of subjects: 1207

Group type: COMPARATOR
Intervention: Caffeinated instant coffee (568 women)
Number of subjects: 1207
Study: 15474548

Group type: EXPERIMENTAL
Intervention: Easy cell phone conversation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Difficult cell phone conversation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No cell phone conversation (implied control)
Number of subjects: 0
Study: 12499031

Group type: EXPERIMENTAL
Intervention: 30 microg ethinylestradiol/150 microg levonorgestrel (LNG)
Number of subjects: 140

Group type: COMPARATOR
Intervention: 35 microg ethinylestradiol/250 microg norgestimate (NGM)
Number of subjects: 140
Study: 9879695

Group type: EXPERIMENTAL
Intervention: Clinical parameters (age, degree of coma, reflex changes)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Laboratory parameters (CSF cell and protein content, haemagglutination inhibition titre)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Neurophysiological parameters (EEG, EMG, sensory and motor evoked potentials)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Radiological changes
Number of subjects: 28
Study: 8021910

Group type: EXPERIMENTAL
Intervention: Nifedipine coat core 30 mg once daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Nifedipine coat core 60 mg once daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Nifedipine coat core (both doses)
Number of subjects: 19
Study: 3415882

Group type: EXPERIMENTAL
Intervention: Premedication with diazepam 0.14 mg kg‐1 by mouth
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Premedication with hyoscine 6 micrograms kg‐1 + morphine 0.2 mg kg‐1 i.m.
Number of subjects: 8

Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lignocaine 1 mg kg‐1 rapid i.v. injection
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Assessment of AAG and albumin plasma protein fractions
Number of subjects: 8
Study: 31667572

Group type: EXPERIMENTAL
Intervention: Trastuzumab monotherapy (arm A)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Trastuzumab plus mono-chemo-agent (arm B)
Number of subjects: 78
Study: 29228386

Group type: EXPERIMENTAL
Intervention: Solution-Focused Brief Therapy (SFBT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 40
Study: 28738912

Group type: EXPERIMENTAL
Intervention: Culturally adapted lifestyle intervention (7 group sessions over 4 months)
Number of subjects: 96
Study: 25967354

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment for 2 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated group (SHOX-D)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GH-treated group (TS)
Number of subjects: 0
Study: 23743310

Group type: EXPERIMENTAL
Intervention: 9 months of isoniazid
Number of subjects: 215

Group type: COMPARATOR
Intervention: 4 months of rifampicin
Number of subjects: 215
Study: 21255526

Group type: EXPERIMENTAL
Intervention: Exenatide 5 μg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exenatide 10 μg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exenatide (both doses)
Number of subjects: 30
Study: 19451281

Group type: EXPERIMENTAL
Intervention: Liposomal amikacin 500 mg by inhalation once daily for 14 days
Number of subjects: 24
Study: 16815138

Group type: EXPERIMENTAL
Intervention: House dust mite (HDM) avoidance
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Dietary modification
Number of subjects: 616

Group type: COMPARATOR
Intervention: Control group for HDM avoidance
Number of subjects: 616

Group type: COMPARATOR
Intervention: Control group for dietary modification
Number of subjects: 616
Study: 14688521

Group type: EXPERIMENTAL
Intervention: Streptokinase preflush
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11125606

Group type: EXPERIMENTAL
Intervention: Ketorolac administered preoperatively (n = 25)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Ketorolac administered at the conclusion of surgery (Control group, n = 24)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Comparison of pain scores using M-VAS
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Total fentanyl use and postoperative oral analgesic requirements
Number of subjects: 49
Study: 9166164

Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam for 72 hours followed by amoxicillin-clavulanate
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Ampicillin for 72 hours followed by amoxicillin
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 8222197

Group type: EXPERIMENTAL
Intervention: Carpentier‐Edwards (C‐E) valve
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Medtronic Hancock I (H) valve
Number of subjects: 174